Aarti Drugs Ltd has already procured land for further expanding its existing Metformin Capacity to 3000 TPM in a brown field expansion. This expansion would be a 2 phase expansion program. The company will start the Phase I expansion project to 2000 TPM in FY20-21. Additional CAPEX is being done for introducing new products in anti-diabetic category towards the end of FY20-21.
Shares of AARTI DRUGS LTD. was last trading in BSE at Rs.679.9 as compared to the previous close of Rs. 674.2. The total number of shares traded during the day was 85895 in over 6329 trades.
The stock hit an intraday high of Rs. 698.35 and intraday low of 653.85. The net turnover during the day was Rs. 58657250.